Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-011-6
CAS number: 2602-34-8
In this CoR 1 study, conducted on male and femal Wistar rats according
to OECD Test Guideline 408 and in compliance with GLP, treatment with
Silane, Triethoxy [2-(7-OxaBicyclo[4.1.0]Hept-3yl)Ethyl]- for 90 days
produced only minimal changes that were not accompanied by any evidence
of organ dysfunction. Based on these results, a No Observed Adverse
Effect Level (NOAEL) of 1,000 mg/kg/day was concluded for repeated dose
oral exposure to Silane, Triethoxy
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Tato webová stránka používá cookies, aby se vám naše stránky používaly co nejlépe.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again